Their primary mechanisms of action include: Enhancing insulin secretion from pancreatic beta cells in a glucose-dependent manner, which helps lower blood sugar levels with a low risk of hypoglycaemia when used alone (though risk increases when combined with insulin or sulfonylureas) Suppressing glucagon release from pancreatic alpha cells, reducing hepatic glucose production Slowing gastric emptying , which prolongs the feeling of fullness after meals Acting on appetite centres in the brain , particularly the hypothalamus, to reduce hunger and food intake These combined effects result in improved glycaemic control for people with diabetes and significant weight loss
Nerve Pain Management Supports healthy nerve functioning and reduces discomfort
Rhrborn D, Eckel J, Sell H
Evolv appears to have done early, sensible work on a new dietary ingredient, recognising hurdles like DPP-4 breakdown and oral absorption, engineering around them, and assembling safety data for New Dietary Ingredient Notification (NDIN) review
Some patients find Saxendas daily dosing more intuitive, and others appreciate that it produces less intense gastrointestinal effects during titration
If palpitations are severe, persistent, or significantly impact quality of life despite these measures, discontinuation of Wegovy may be considered in consultation with the prescribing clinician